These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 38990436)

  • 1. Transcriptome Analysis of Human Dermal Cells Infected with Candida auris Identified Unique Pathogenesis/Defensive Mechanisms Particularly Ferroptosis.
    Fayed B; Shakartalla SB; Sabbah H; Dalle H; Tannira M; Senok A; Soliman SSM
    Mycopathologia; 2024 Jul; 189(4):65. PubMed ID: 38990436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome Assembly and Profiling of
    Kean R; Delaney C; Sherry L; Borman A; Johnson EM; Richardson MD; Rautemaa-Richardson R; Williams C; Ramage G
    mSphere; 2018 Jul; 3(4):. PubMed ID: 29997121
    [No Abstract]   [Full Text] [Related]  

  • 3. Transcriptional Profiling of the Candida auris Response to Exogenous Farnesol Exposure.
    Jakab Á; Balla N; Ragyák Á; Nagy F; Kovács F; Sajtos Z; Tóth Z; Borman AM; Pócsi I; Baranyai E; Majoros L; Kovács R
    mSphere; 2021 Oct; 6(5):e0071021. PubMed ID: 34643421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Markerless CRISPR-Mediated System for Genome Editing in Candida auris Reveals a Conserved Role for Cas5 in the Caspofungin Response.
    Ennis CL; Hernday AD; Nobile CJ
    Microbiol Spectr; 2021 Dec; 9(3):e0182021. PubMed ID: 34730409
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Romera D; Aguilera-Correa JJ; Gadea I; Viñuela-Sandoval L; García-Rodríguez J; Esteban J
    J Med Microbiol; 2019 Sep; 68(9):1353-1358. PubMed ID: 31271350
    [No Abstract]   [Full Text] [Related]  

  • 6. Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen.
    Dekkerová J; Lopez-Ribot JL; Bujdáková H
    Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):101-108. PubMed ID: 30327897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenylyl Cyclase and Protein Kinase A Play Redundant and Distinct Roles in Growth, Differentiation, Antifungal Drug Resistance, and Pathogenicity of
    Kim JS; Lee KT; Lee MH; Cheong E; Bahn YS
    mBio; 2021 Oct; 12(5):e0272921. PubMed ID: 34663094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
    Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
    [No Abstract]   [Full Text] [Related]  

  • 9. Candida auris susceptibility on surfaces coated with the antifungal drug caspofungin.
    Lamont-Friedrich SJ; Kidd SE; Giles C; Griesser HJ; Coad BR
    Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34850067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida auris Phenotypic Heterogeneity Determines Pathogenicity
    Brown JL; Delaney C; Short B; Butcher MC; McKloud E; Williams C; Kean R; Ramage G
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581078
    [No Abstract]   [Full Text] [Related]  

  • 11. Transcriptional Response of Candida auris to the Mrr1 Inducers Methylglyoxal and Benomyl.
    Biermann AR; Hogan DA
    mSphere; 2022 Jun; 7(3):e0012422. PubMed ID: 35473297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and Extracellular Vesicle RNA Analysis in the Global Threat Fungus
    Munhoz da Rocha IF; Martins ST; Amatuzzi RF; Zamith-Miranda D; Nosanchuk JD; Rodrigues ML; Alves LR
    Microbiol Spectr; 2021 Dec; 9(3):e0153821. PubMed ID: 34908466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspofungin-resistance in Candida auris is cell wall-dependent phenotype and potential prevention by zinc oxide nanoparticles.
    Fayed B; Jayakumar MN; Soliman SSM
    Med Mycol; 2021 Dec; 59(12):1243-1256. PubMed ID: 34612496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of nine antifungal agents against Candida auris biofilms.
    Chatzimoschou A; Giampani A; Meis JF; Roilides E
    Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressing the virulence factors of Candida auris with baicalein through multifaceted mechanisms.
    Li C; Wang J; Li H; Wang Y; Wu H; Wei W; Wu D; Shao J; Wang T; Wang C
    Arch Microbiol; 2024 Jul; 206(8):349. PubMed ID: 38992278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol.
    Srivastava V; Ahmad A
    PLoS One; 2020; 15(5):e0233102. PubMed ID: 32392266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative transcriptional analysis of
    Jakab Á; Kovács F; Balla N; Nagy-Köteles C; Ragyák Á; Nagy F; Borman AM; Majoros L; Kovács R
    Microbiol Spectr; 2024 Apr; 12(4):e0227823. PubMed ID: 38440972
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
    Vediyappan G; Rossignol T; d'Enfert C
    Antimicrob Agents Chemother; 2010 May; 54(5):2096-111. PubMed ID: 20194705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upc2-mediated mechanisms of azole resistance in
    Li J; Aubry L; Brandalise D; Coste AT; Sanglard D; Lamoth F
    Microbiol Spectr; 2024 Feb; 12(2):e0352623. PubMed ID: 38206035
    [No Abstract]   [Full Text] [Related]  

  • 20. Delineation of the Direct Contribution of Candida auris
    Rybak JM; Sharma C; Doorley LA; Barker KS; Palmer GE; Rogers PD
    Microbiol Spectr; 2021 Dec; 9(3):e0158521. PubMed ID: 34878305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.